HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Congenital cerebellar malignant rhabdoid tumor in an infant with junctional epidermolysis bullosa.

Abstract
Epidermolysis bullosa (EB), a hereditary blistering condition of the skin, is divided into simplex, hemidesmosomal, junctional, and dystrophic types. It may be complicated by the development of squamous cell carcinoma of the skin, but other neoplasms, especially those separate from involved skin, are distinctly rare. We report a male infant with junctional EB who died of Pseudomonas sepsis and was found at autopsy to have a clinically unrecognized cerebellar malignant rhabdoid tumor (MRT). This is the first reported case of an infant with EB and a coincident extracutaneous neoplasm. It is also the first known case of EB associated with a pathologically confirmed malignant brain tumor. Cytogenetic results from the infant and his tumor and both of his parents suggest the infant's EB and MRT were not genetically linked.
AuthorsHenry F Krous, Amy E Chadwick, Elisabeth A Haas, Eric Breisch, Homeyra Masoumi
JournalPediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society (Pediatr Dev Pathol) Vol. 10 Issue 6 Pg. 481-6 ( 2007) ISSN: 1093-5266 [Print] United States
PMID18001159 (Publication Type: Case Reports, Journal Article)
Topics
  • Cerebellar Neoplasms (complications, congenital, pathology)
  • Epidermolysis Bullosa, Junctional (complications, pathology)
  • Fatal Outcome
  • Humans
  • Infant
  • Male
  • Pseudomonas Infections (complications, diagnosis)
  • Pseudomonas aeruginosa (isolation & purification)
  • Rhabdoid Tumor (complications, congenital, pathology)
  • Sepsis (diagnosis, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: